Monthly News Roundup - April 2015
FDA Approves First-Time Generic for BMS’s Abilify
Abilify (aripiprazole) is a blockbuster atypical antipsychotic drug used to treat the mental illnesses schizophrenia and bipolar disorder. On April 28th, the U.S. Food and Drug Administration...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Abilify | Bipolar | Food and Drug Administration (FDA) | Mania | Men | Pharmaceuticals | Schizophrenia